Brief: Simris Biologics Awarded EUR 0.2 Mln Funding For R&D Programme
12/09/2025 09:02
Sept 12 (Reuters) - Simris Group AB SIMRISb.ST: SIMRIS BIOLOGICS AWARDED EUR 200K IN NON-DILUTIVE FUNDING FOR RESEARCH AND DEVELOPMENT PROGRAMME TO FURTHER DEVELOP MICROCYSTIN PAYLOADS FOR ANTIBODY DRUG CONJUGATES (ADCS) GRANT PROVIDES EUR 201K TO SIMRIS AND EUR 186K TO FREIE UNIVERSITÄT BERLIN OVER THREE YEARS, STARTING SEPTEMBER 1, 2025 Source text: ID:nMFN1BhXX4 Further company coverage: [SIMRISb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))